Trademarkia Logo

Canada

C$
FIRST WAVE BIOPHARMA
ABANDONED SECTION 36

on 16 May 2024

Last Applicant/ Owned by

FIRST WAVE BIOPHARMA INC.

777 Yamato Road, Suite 502Boca Raton FL 33431

US

Serial Number

2180672 filed on 3rd Mar 2022

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

FIRST WAVE BIOPHARMA

Trademark usage description

biological research and analysis; industrial research in the field of gastroenterology, gastrohepatology, inflammatory diseases, infectious diseases, Read More

Vienna Information


1 . 15 . 24

Waves -- Note: Not including waves represented by wavy lines (26.11.1 to 26.11.3).Vagues -- Note: Non compris les vagues représentées par des lignes ondulées (26.11.1 à 26.11.3).

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 11 . 13

Wavy lines or bands, zigzag lines or bandsLignes ou bandes ondulées, en dents de scie

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 11

Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

Classification Information


Class [042]
Biological research and analysis; industrial research in the field of gastroenterology, gastrohepatology, inflammatory diseases, infectious diseases, and pharmaceuticals for the treatment thereof; pharmaceutical drug development services; pharmaceutical research and development; research and development in the field of pharmaceuticals and pharmaceutical therapies for the treatment of gastrointestinal (GI) diseases, inflammatory diseases, inflammatory bowel diseases (IBD), ulcerative colitis, ulcerative proctitis, Crohn's disease, immune checkpoint inhibitor-associated colitis (ICI-AC), exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis and chronic pancreatitis, infectious diseases, and COVID-19 gastrointestinal infections; research in the field of biopharmaceuticals; scientific research and development.


Classification kind code

11

Mark Details


Serial Number

2180672

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 10th Aug 2023
Search Recorded
Submitted for opposition 20
on 10th Aug 2023
Examiner's First Report
Submitted for opposition 223
on 10th Aug 2023
Total Provisional Refusal
Submitted for opposition 256
on 21st Feb 2023
Notification of Possible Opposition Sent
Submitted for opposition 48
on 10th May 2022
Agent Changed
Submitted for opposition 257
on 21st Apr 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 21st Apr 2022
Created
Submitted for opposition 31
on 21st Apr 2022
Formalized
Submitted for opposition 30
on 3rd Mar 2022
Filed
Submitted for opposition 228
on 3rd Mar 2022
International Registration